gine and oral antidiabetic drugs. Diabetes Obes Metab . 2008;10: 1178-1185. 15.Bergenstal RM, Johnson M, Powers MA, et al. Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine. Diabetes Care . 2008;31:1305-1310. 16.Owens DR, Luzio SD, Sert-Langeron C, Riddle MC. Effects of initia- tion and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a6-month ‘proof-of-concept ’study. Diabetes Obes Metab . 2011;13: 1020-1027. 17.Edelman SV, Liu R, Johnson J, Glass LC. AUTONOMY: the first ran- domized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes. Diabetes Care . 2014;37:2132-2140. 18.Eng C, Kramer CK, Zinman B, Retnakaran R. Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and